BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35072237)

  • 1. Ultrasound differentiation between benign versus malignant adnexal masses in pregnant patients.
    Rabiej-Wronska E; Wiechec M; Pitynski K; Wiercinska E; Kotlarz A
    Ginekol Pol; 2022; 93(8):643-649. PubMed ID: 35072237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
    Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
    Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
    Auekitrungrueng R; Tinnangwattana D; Tantipalakorn C; Charoenratana C; Lerthiranwong T; Wanapirak C; Tongsong T
    Int J Gynaecol Obstet; 2019 Sep; 146(3):364-369. PubMed ID: 31206642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.
    Timmerman D; Ameye L; Fischerova D; Epstein E; Melis GB; Guerriero S; Van Holsbeke C; Savelli L; Fruscio R; Lissoni AA; Testa AC; Veldman J; Vergote I; Van Huffel S; Bourne T; Valentin L
    BMJ; 2010 Dec; 341():c6839. PubMed ID: 21156740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound examination, MRI, or ROMA for discriminating between inconclusive adnexal masses as determined by IOTA Simple Rules: a prospective study.
    Chacon E; Arraiza M; Manzour N; Benito A; Mínguez JÁ; Vázquez-Vicente D; Castellanos T; Chiva L; Alcazar JL
    Int J Gynecol Cancer; 2023 Jun; 33(6):951-956. PubMed ID: 37055169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.
    Timmerman D; Van Calster B; Testa A; Savelli L; Fischerova D; Froyman W; Wynants L; Van Holsbeke C; Epstein E; Franchi D; Kaijser J; Czekierdowski A; Guerriero S; Fruscio R; Leone FPG; Rossi A; Landolfo C; Vergote I; Bourne T; Valentin L
    Am J Obstet Gynecol; 2016 Apr; 214(4):424-437. PubMed ID: 26800772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence.
    Ruiz de Gauna B; Rodriguez D; Olartecoechea B; Aubá M; Jurado M; Gómez Roig MD; Alcázar JL
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():10-4. PubMed ID: 26066289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IOTA simple rules in differentiating between benign and malignant ovarian tumors.
    Tantipalakorn C; Wanapirak C; Khunamornpong S; Sukpan K; Tongsong T
    Asian Pac J Cancer Prev; 2014; 15(13):5123-6. PubMed ID: 25040961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
    Tian C; Wen SB; Zhao CY; Yan XN; Du JX
    BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of IOTA simple descriptors and simple rules for classifying adnexal masses.
    Alcázar JL; Pascual MA; Graupera B; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana A; Hereter L; Ajossa S; Guerriero S
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):397-402. PubMed ID: 26748432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of International Ovarian Tumor Analysis Simple Rules to Society of Radiologists in Ultrasound Guidelines for Detection of Malignancy in Adnexal Cysts.
    Patel-Lippmann KK; Sadowski EA; Robbins JB; Paroder V; Barroilhet L; Maddox E; McMahon T; Sampene E; Wasnik AP; Blaty AD; Maturen KE
    AJR Am J Roentgenol; 2020 Mar; 214(3):694-700. PubMed ID: 31770022
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Effectiveness in Differentiating Benign from Malignant Ovarian Masses between IOTA Simple Rules and Subjective Sonographic Assessment.
    Tongsong T; Tinnangwattana D; Vichak-Ururote L; Tontivuthikul P; Charoenratana C; Lerthiranwong T
    Asian Pac J Cancer Prev; 2016; 17(9):4377-4380. PubMed ID: 27797247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Simple Ultrasound Rules by International Ovarian Tumor Analysis (IOTA) with RMI-1 and RMI-4 (Risk of Malignancy Index) in Preoperative Differentiation of Benign and Malignant Adnexal Masses.
    Dewangan S; Gupta S; Chawla I
    J Obstet Gynaecol India; 2024 Apr; 74(2):158-164. PubMed ID: 38707882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Malignancy in Adnexal Masses by the International Ovarian Tumor Analysis-Simple Rules.
    Solanki V; Singh P; Sharma C; Ghuman N; Sureka B; Shekhar S; Gothwal M; Yadav G
    J Midlife Health; 2020; 11(4):217-223. PubMed ID: 33767562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IOTA Simple Rules in Differentiating between Benign and Malignant Adnexal Masses by Non-expert Examiners.
    Tinnangwattana D; Vichak-Ururote L; Tontivuthikul P; Charoenratana C; Lerthiranwong T; Tongsong T
    Asian Pac J Cancer Prev; 2015; 16(9):3835-8. PubMed ID: 25987045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prospective External Validation of International Ovarian Tumor Analysis (IOTA) Simple Rules in the Hands of Level I and II Examiners.
    Knafel A; Banas T; Nocun A; Wiechec M; Jach R; Ludwin A; Kabzinska-Turek M; Pietrus M; Pitynski K
    Ultraschall Med; 2016 Oct; 37(5):516-523. PubMed ID: 26126150
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology.
    Van Holsbeke C; Van Belle V; Leone FP; Guerriero S; Paladini D; Melis GB; Greggi S; Fischerova D; De Jonge E; Neven P; Bourne T; Valentin L; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2010 Jul; 36(1):81-7. PubMed ID: 20217895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.